Avalon Labs vs Bio Protocol — how do they compare? Avalon Labs trades at Rp286.59 (market cap Rp46,91M, Rp15,38M 24h volume), while Bio Protocol trades at Rp436.5 (market cap Rp999,49M, Rp162,68M 24h volume). The key difference: Bio Protocol is far larger — about 21.3× Avalon Labs's market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 9 Days and Bio Protocol for 18 Days on average.
| AVL | BIO | |
|---|---|---|
Market Cap | Rp46,91M | Rp999,49M |
Volume (24h) | Rp15,38M | Rp162,68M |
Circulating Supply | 161,7M / 1B AVL (17%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 9 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
AVL is trading at Rp286.54 with a bearish technical outlook, showing sell signals across moving averages while oscillators remain neutral. The token faces resistance at Rp288 with support at Rp280, indicating potential downside pressure. With only 17% of max supply circulating and average hold time of 9 days, liquidity remains limited. Recent news shows no direct crypto ecosystem developments for this token.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential breakout above Rp288 resistance, while major risks include low liquidity, limited circulation, and absence of recent protocol updates. Investors should monitor for any blockchain ecosystem developments that could drive adoption.
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →